tm logo
MIRAPEUTICS
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 23 Apr 2024

Last Applicant/ Owned by

One Kendall Square

Cambridge

MA

02139

Serial Number

90879030 filed on 12th Aug 2021

Registration Number

N/A

Correspondent Address

CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.

600 ATLANTIC AVENUE

BOSTON, MA 02210

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MIRAPEUTICS

scientific research, pharmaceutical research, medical research; biotechnology research; technical scientific consultation and product development for others in the field of biotechnology and the development of protein-based pharmaceuticals, diagnostics, biomaterials, industrial reagents, agricultural products, cosmetics, consumer products and nutrition products proteins for use in manufacture; prRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


scientific research, pharmaceutical research, medical research; biotechnology research; technical scientific consultation and product development for others in the field of biotechnology and the development of protein-based pharmaceuticals, diagnostics, biomaterials, industrial reagents, agricultural products, cosmetics, consumer products and nutrition products


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [005]
Pharmaceutical Products


protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, artificially produced peptides and proteins for use in the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, and fungal diseases and disorders; therapeutic pharmaceuticals, namely, artificially produced peptides and proteins for the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders, none of the foregoing pertaining to Parkinson's Disease or Restless Legs Syndrome


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [001]
Chemical Products


proteins for use in manufacture; proteins for industrial use in agriculture, aquaculture, cosmetics, consumer products and nutrition products


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Mark Details


Serial Number

No 90879030

Mark Type

No Service Mark

Attorney Docket Number

No F08762000100

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
23rd Apr 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13th Mar 2024TTAB RELEASE CASE TO TRADEMARKS
13th Mar 2024OPPOSITION TERMINATED NO. 999999
13th Mar 2024OPPOSITION DISMISSED NO. 999999
12th Jan 2024ASSIGNED TO EXAMINER
22nd Feb 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08th Sep 2022OPPOSITION INSTITUTED NO. 999999
08th Aug 2022EXTENSION OF TIME TO OPPOSE RECEIVED
12th Jul 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Jul 2022PUBLISHED FOR OPPOSITION